Browse Lab Results > 2009-0564

Site: Prostate

Inclusion Criteria:

• No Personal History of any Cancer
• No Reported Cancers During Trial
• White, Non-Hispanic
• With 10+ ug of DNA Available
• With 100+ ug of DNA and 4+ Vials of Buffy Coat
• In Pegasus
• With All Necessary Vial-Level Requirements

Matching Factors:

• None

Match Ratio: N/A

Match Technique: N/A

Analytes:

• DNA Methylation

Number of Controls: 80

---

Site: Prostate

Inclusion Criteria:

• White, Non-Hispanic
• No Prior History of Any Cancer
• No Rare Cancers
• No Reported Cancer During Trial in Controls
• With Buffy Coat
• With T0 and T5 Buffy Coat
• With Pegasus GWAS Data Available

Matching Factors:

• None

Match Ratio: N/A

Match Technique: N/A

Analytes:

• DNA Methylation

Number of Cases: 40

Number of Controls: 40

---

Site: Prostate

Inclusion Criteria:

• Males
• White, Non-Hispanic
• Not From Hawaii Center
• Prior History of Any Cancer
• No Controls with Prostate Cancer Prior to Censor Date
• Rare Cancers in Controls
• Specimen Available (1+ ug DNA)
• Cases: Pre-Diagnostic Specimen Available (1+ ug DNA)
• Cases: Prostate Cancer is First Reported Cancer
• Cases: Previously selected for CGEMS, BPC3 or Prostate Aim1

Matching Factors:

• Age at Randomization (5 year intervals)
• Fiscal Year of Randomization
• Year of Blood Draw

Match Ratio: 1 to 1

Match Technique: Frequency matching only non-cases as controls.

Additional Matching Comments: Cases and controls were matched on year of exit using the NDI 07 prostate cancer method

Analytes:

• ALU
• LINE-1

Number of Cases: 707

Number of Controls: 707

---